PenderFund Capital Management’s Tourmaline Bio TRML Stock Holding History

PenderFund Capital Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,000	Closed	-$143K	–	260
2025 Q3	$143K	Buy	+3,000	New	+$83.2K	0.02%	127

PenderFund Capital Management's TRML Position: Q4 2025 in Review

PenderFund Capital Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 3,000 shares — an estimated $143K sold.

PenderFund Capital Management first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $143K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

PenderFund Capital Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
PenderFund Capital Management sold 3,000 Tourmaline Bio shares in Q4 2025, an estimated $143K.
PenderFund Capital Management first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
PenderFund Capital Management's Tourmaline Bio position peaked at $143K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on PenderFund Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.